Program for Friday, April 28th: Talk View

PROGRAM FOR FRIDAY, APRIL 28TH: TALK VIEW

Days:

previous day

next day

all days

View: with abstracts session overview

7:00

7:30

8:00

8:30

9:00

9:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

07:00-08:30 Session 22

08:00-19:00 Session 23

08:30-09:00

From HLA to MICA

Seiamak Barham

09:00-09:30

HLA molecular matching to improve transplant outcomes.

Anat Tambur

09:30-10:00

Guiding pre-transplant desensitization and post-transplant DSA treatment.

Olga Timofeeva

10:30-11:00

KIR immunogenetics and NK cell diversity

Christelle Retière

11:00-11:30

HLA epitopes and matching from a big data perspective

Eric Spierings

10:30-11:00

From Precision Microbial Genomics to Precision Medicine.

Ami Bhatt

11:00-11:30

KIRs, T cell dynamics, control of chronic virus infection and autoimmunity

Becca Asquith

11:30-12:00

Immunogenetics of Hematopoietic Cell Transplantation

Effie Pettersdorf

10:30-10:40

Unexposed individuals are fully equipped at the genetic level in terms of peptide coverage and T-cell repertoire against SARS-CoV-2: analysis in a cohort of healthy donors and alloHSCT

Buhler, Calderin Sollet, Bettens, Schäfer, Ansari, Ferrari-Lacraz, Villard

10:40-10:50

A new hla-mapper algorithm for alignment optimization of HLA sequences from RNA-seq

Erick Castelli, Eduardo Donadi, Celso Mendes-Junior

10:50-11:00

HLA-3Diff: redefining donor-recipients HLA matching based on three dimensional structure prediction

Léo Boussamet, Augustin Moreau, Justine Baron, Sophie Limou, Nicolas Vince

11:00-11:10

Human Leucocyte Antigen variation is associated with Cytomegalovirus seropositivity

Juliano Boquett, Martin Maiers, Jill Hollenbach

11:10-11:20

A large, improved and ancestry-diverse reference panel to impute HLA classical and non-classical class I

Silva et.al

11:20-11:30

Possible Biological Mechanisms Underlying the Association between COVID-19 Severity and HLA-C*04:01

Nersisyan et.al

11:30-11:40

The expanded role of microRNAs in controlling the HLA class I phenotype: Relationship between the 3’ UTR and post-transcriptional Gene

P. Mallis, A. Siorenta, E. Stamathioudaki, V. Vrani, G. Paterakis

11:40-11:50

Analysis of "Big Data" reveals a new MHC Class I sequence, HLA-OLI, and the location of HLA-Y

Nickolai Alexandrov, Lindley Blair, Ting Wang, Brian Nadon, David Sayer

10:30-10:40

Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells

Palmer et.al

10:40-10:50

Memory CD4+ T cells efficiently recognize divergent HLA-DP immunopeptidomes relevant in allogeneic hematopoietic cell

Kittissares et.al

10:50-11:00

Discovery of the human cytomegalovirus-specific peptide repertoire naturally processed and presented by infected human antigen presenting

Santamorena et.al

11:00-11:10

Exploring the cryptic HLA-DP immunopeptidome for new targets of T cell immunotherapy in acute myeloid

Crivello et.al

11:10-11:20

Generation and Characterization of third party donor derived AdV, CMV and EBV multivirus specific T cells for therapeutic intervention in patients undergoing Hematopoietic Stem Cell

Singh, Kota, Bhosale, Chichra, Jindal, Punatar, Gokarn, Mirgh, D'Silva, Khattry

11:20-11:30

Optimal population coverage for cellular therapies

Sapir Israeli, Elizabeth Krakow, Martin Maiers, Corrine Summers, Yoram Louzoun

11:30-11:40

THE STIMULATION OF MEMORY B CELLS FOR THE IDENTIFICATION OF UNACCEPTABLE ANTIGENS IN SOLID ORGAN

S. Bruce, L. Truong, J. Downing, D. De Santis, P. Martinez, L. D'Orsogna

11:40-11:50

New regulatory dimensions for transplantation, genetics and stem cell research in the French bioethics law. Consequences for European

Emmanuelle Rial-Sebbag, Anne Cambon-Thomsen, Anne-Marie Duguet

12:00-14:00 SIP Board meeting

12:10-13:10 Luncheon Industry symposium: GenDx

13:20-14:20 Luncheon Industry symposium: One Lambda Inc. A Thermo Fisher Scientific Brand

13:30-14:30 EBTI GA

14:30-15:00

Pinpointing HLA selection signal in admixed populations

Yang Luo

15:00-15:30

Application of machine learning to prediction of immunosuppressant exposure, the example of

Jean-Baptiste Woillard

14:30-16:00 Meet the Experts & Young EFI Group

14:30-14:40

HLA-DP permissive mismatch subsets confer reduced aGvHD risks and improved disease control after hematopoietic cell transplantation for acute leukemia and myelodysplastic

Arrieta Bolaños et.al

14:40-14:50

T cells can be activated by epitopes presented on HLA-C*04:09N

Welters, Welters, Stadler, Dhamodaran, Bullinger, Blankenstein, Hansmann

14:50-15:00

Longitudinal tracking of T – cell receptor repertoire reconstitution after allogeneic hematopoietic stem cell

Schäfer et.al

15:00-15:10

Associations between HLA Evolutionary Divergence and clinical outcome of matched related or unrelated stem cell transplantation: a study from the EBMT Cellular Therapy and Immunobiology Working

Crivello et.al

15:10-15:20

The role of Recipient Specific Antibodies (RSA) in transplant outcome. Analysis of a group of family donors selected for patients undergoing haploidentical

Cacciatore et.al

15:20-15:30

HLA evolutionary divergence (HED) influences the outcome of haploidentical hematopoietic stem cell transplantation in adult patients with hematological

Jorge Cordeiro, Villemonteix, Xhaard, Ferrary, A. Lima, Allain, Caillat-Zucman

15:30-15:40

Combined imputation of HLA genotype and race leads to better donor-recipient matching

Israeli, Maiers, Gragert, Schneider, Madbouly, Bayshal, Louzoun

15:40-15:50

Genetic variation in HLA genes: impact on transplant compatibility in a Brazilian admixed population

Andrade et.al

14:30-14:40

A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited from Neanderthals in the Sardinian

Mocci et.al

14:40-14:50

HLA-A*03:01 significantly predicts strong humoral response at six months after mRNA vaccination: results from the observational prospective cohort study

Crocchiolo et.al

14:50-15:00

NEGR1 genetic variants and risk for virological failure in the HIV-positive Botswanian population

Morin, Winkler, Bussmann, Novitsky, Moyo, Essex, Marlink, Wester, Limou

15:00-15:10

Copy number variation of the C4L gene isoform is associated with risk for multiple sclerosis”

Williams, Augusto, Marin, Kizer, Wade, Caillier, Oksenberg, Hollenbach

15:10-15:20

To study the HLA-E expression in HPV infected Cervical Carcinoma

R. Aggarwal, N. Mangat, T. Bhatia, M. Sharma, J. Kaur, V. Suri, R. Minz

15:20-15:30

HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2

Benedek, Aharon, Barhoum, Parnasa, Magadle, Perzon, Mevorach

15:30-15:40

HLA-Bw4 is Associated with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Kizer et.al

15:40-15:50

Fight against COVID-19: functional and structural study of the T cell response

Stephanie Gras

14:30-15:30 Industry Symposium: Omixon

16:30-17:00

Fine-mapping complex loci for autoimmune diseases

Soumya Raychaudhuri

17:00-17:30

Using transcriptome data to stratify and predict treatment responses in lupus and other systemic autoimmune

Marta Alarcón-Riquelme

17:30-18:00

Using tissue and cell type-specific gene regulatory networks to predict driver genes of common

Patrick Deelen

18:00-19:30 EFI GENERAL ASSEMBLY

10:00-10:30 Coffee Break

12:00-12:10 Coffee Break

16:00-16:30 Coffee Break